Optimizing Botox regimens in patients with adductor spasmodic dysphonia and essential tremor of voice: A 31‐year experience
Abstract Objective The purpose of this study was to quantitatively compare the effectiveness of unilateral and bilateral botulinum toxin A (BTX‐A) injections for mitigating undesirable weak/breathy voice quality and dysphagia for patients with adductor spasmodic dysphonia and/or essential tremor of...
Main Authors: | Amy Stone, Maria E. Powell, Kaitlyn Hamers, K. Charles Fletcher, David O. Francis, Mark S. Courey, James L. Netterville, C. Gaelyn Garrett |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-10-01
|
Series: | Laryngoscope Investigative Otolaryngology |
Subjects: | |
Online Access: | https://doi.org/10.1002/lio2.915 |
Similar Items
-
Significance of age and sex in botulinum neurotoxin dosing for adductor spasmodic dysphonia
by: Richard Heyes, et al.
Published: (2023-06-01) -
An Auditory-Perceptual and Pupillometric Study of Vocal Strain and Listening Effort in Adductor Spasmodic Dysphonia
by: Mojgan Farahani, et al.
Published: (2020-08-01) -
Long-term Dose Stability of OnabotulinumtoxinA Injection for Adductor Spasmodic Dysphonia: A 19-Year Single Institution Experience
by: Paul Paddle, et al.
Published: (2017-11-01) -
Machine Learning Assessment of Spasmodic Dysphonia Based on Acoustical and Perceptual Parameters
by: Federico Calà, et al.
Published: (2023-03-01) -
Post‐treatment clinical course following botulinum toxin injection therapy for adductor spasmodic dysphonia: Analysis of data from a placebo‐controlled, randomized, double‐blinded clinical trial in Japan
by: Kahori Hirose, et al.
Published: (2021-10-01)